In A Nutshell Metformin, a common diabetes medication costing less than $10 monthly, was linked to 37% fewer cases of progression to intermediate macular degeneration over five years. The study ...

This finding was based on the results of a study published in BMJ Open Ophthalmology1 that patients with diabetes who were ...

Doctors have found that metformin, an everyday medicine for diabetes, is associated with less progression of age-related macular degeneration (AMD), the most common cause of blindness in western ...

Doctors have found that metformin, an everyday medicine for diabetes, is associated with less progression of age-related macular degeneration (AMD), the commonest cause of blindness in western ...

Patients who live in rural communities, Hispanic patients and Black patients with pre-existing diabetic retinopathy are less likely to receive annual diabetic eye exams than white patients, according ...

Free screenings to help prevent vision loss for people with diabetes are happening this Saturday at Wills Eye Hospital in Philadelphia on Diabetic Eye Screening Day. Jack Mathers gets routine ...

Diabetic eye disease is the leading cause of blindness among people ages 40 to 60. The longer you have diabetes, the greater your likelihood of developing vision problems increases. Keeping blood ...

Continuous glucose monitoring (CGM) is associated with reduced risk of diabetic retinopathy and proliferative diabetic retinopathy in type 1 diabetes patients. Language barriers and limited health ...

New blood vessels in your eye can signal eye disease. This is called neovascularization, and it’s often a sign of diabetes-related retinopathy. When your body makes new blood vessels in places they ...

November is Diabetes-related Eye Disease Awareness Month, and early detection and treatment of diabetes are key to reduce the risk for significant vision loss and blindness, according to Prevent ...

Diabetes patients on tirzepatide have lower risks for new or worsening diabetic retinopathy, eye complications, and the need for eye treatments than those relying on lifestyle interventions alone.